Evidence map›Paper›PMID 39283637›Full record

ArticleJAMA network open2024

West African Genetic Ancestry, Neighborhood Deprivation, and Prostate Cancer.

Catherine M Pichardo, Adaora Ezeani, Amanda M Acevedo, Tanya Agurs-Collins, Maeve Bailey-Whyte, Tiffany H Dorsey, Alexandra R Harris, Jamirra Franklin, Rick A Kittles, Wayne R Lawrence and 8 more

Erratum issuedAbstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Error in Abstract and Results.JAMA network open · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Catherine M PichardoDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Adaora EzeaniDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Amanda M AcevedoDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Tanya Agurs-CollinsDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Maeve Bailey-WhyteLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Tiffany H DorseyLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Alexandra R HarrisLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Jamirra FranklinLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Rick A KittlesDepartment of Community Health and Preventive Medicine, Morehouse School of Medicine, Atlanta, Georgia.
Wayne R LawrenceDivision of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Christopher A LoffredoCancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
Tsion Zewdu MinasLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Margaret S PichardoDepartment of Surgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia.
Brid M RyanLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Wei TangLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
William WootenUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Biostatistics Shared Service, Baltimore.
Jia LiuCancer Genomics Research Laboratory, National Cancer Institute, Rockville, Maryland.
Stefan AmbsLaboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Funding

Maryland Prostate Cancer Case-Control StudyZIABC010499 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI AMBS, STEFAN · 2009 to 2025
$11.4M
Intramural NIH HHS ZIA BC010499
6 · The paper itself

Abstract

Importance: Racial disparities in prostate cancer are likely the result of complex relationships between both socioeconomic and environmental factors captured by the neighborhood environment and genetic factors, including West African genetic ancestry. However, few studies have examined the combined role of neighborhood environment and genetic ancestry in developing lethal prostate cancer. Objective: To examine the interactions between West African genetic ancestry and neighborhood deprivation in modifying prostate cancer risk and mortality. Design, Setting, and Participants: This case-control study was conducted in the Greater Baltimore area. Participants included men of African and European descent (617 cases with prostate cancer, 852 controls without prostate cancer) enrolled between January 2005 and January 2016. Follow-up was performed through December 31, 2020, using the National Death Index. Analysis was conducted from August 2023 to January 2024. Exposure: Included exposures were West African genetic ancestry, derived from large-scale genotyping, and neighborhood deprivation, defined using 2000 census-tract-level Neighborhood Deprivation Index (NDI) score. Main Outcomes and Measures: Outcomes of interest were prostate cancer and all-cause mortality. Results: Among a total of 1469 participants (mean [SD] age, 64.96 [7.95] years), there were 736 self-identified Black and 733 White men, and the mean (range) proportion of West African genetic ancestry was 0.27 (0.04-0.84) among participants residing in areas with low levels of deprivation and 0.48 (0.07-0.83) among participants residing in areas with high levels of deprivation. Multivariable logistic regression analysis revealed a significant multiplicative interaction of West African genetic ancestry and neighborhood deprivation with the odds of a prostate cancer diagnosis (P for interaction = .02). Among individuals living in neighborhoods with high NDI scores, West African genetic ancestry was associated with increased odds of a prostate cancer diagnosis (age-adjusted odds ratio [OR], 1.98; 95% CI, 1.23-3.19). In contrast, West African genetic ancestry was associated with reduced odds of this diagnosis among individuals residing in areas with medium to low levels of deprivation (age-adjusted OR, 0.22; 95% CI, 0.11-0.44). There was no significant multiplicative interaction between West African genetic ancestry and neighborhood deprivation for all-cause mortality (P for interaction = .44). The positive association of neighborhood deprivation with prostate cancer was independent of West African genetic ancestry (age- and West African ancestry-adjusted OR, 1,70; 95% CI, 1.50-1.94). Conclusions and Relevance: This case-control study of men with West African and European ancestry found that West African genetic ancestry was associated with increased odds of prostate cancer among males who resided in neighborhoods with high deprivation but lower odds in more affluent neighborhoods. Thus, neighborhood environments may play a critical role in defining how genetic ancestry modulates prostate cancer risk.

Indexed as

Prostatic NeoplasmsAfrica, WesternAgedBaltimoreBlack or African AmericanBlack PeopleCase-Control StudiesHumansMaleMiddle AgedNeighborhood CharacteristicsRisk FactorsWhite

Identifiers

PMID39283637
PMCPMC11406387

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.